Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Cancer ; 23(1): 1123, 2023 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-37978466

RESUMO

BACKGROUND: There are significant differences in the incidence and risk factors of tumor patients, and there is no relevant statistical data. Therefore, this study aims to clarify the incidence and risk factors of acute kidney injury (AKI) in malignant tumor patients and compare critically ill patients with non-critically ill patients. METHODS: Relevant literature on the occurrence of AKI in malignant tumors was retrieved from databases. Two authors independently screened and evaluated the eligibility and quality of the literature and extracted the data. The Stata 12.0 software was used for meta-analysis. RESULTS: A total of 3922 articles were initially retrieved, and 24 articles were finally included, 8 of which were about critically ill malignant tumor patients, and 16 were about malignant tumor patients. Among the 4107 patients included in the 8 studies on critically ill malignant tumors, 1932 developed AKI, with an incidence rate of 52% (95%CI 34-70%, I2 = 99%). The risk factors for AKI in critically ill malignant tumor patients were sepsis and hypovolemia, which were different from those in non-critically ill patients. Among the 292,874 patients included in the 16 studies on malignant tumors, 51,211 developed AKI, and the combined incidence rate was 24% (95%CI 17-30%, I2 = 100%). The risk factors for AKI in critical malignant tumor patients were sepsis and hypovolemia. CONCLUSION: This meta-analysis shows that the incidence of AKI in critically ill malignant tumor patients is consistent with that in other critically ill patients, and independent risk factors are sepsis and hypovolemia. The incidence of AKI in malignant tumor patients is higher than that in other patients, and tumor is a risk factor for AKI. This study has been registered in INPLASY (INPLASY202320079),Registered February 18,2023.


Assuntos
Injúria Renal Aguda , Neoplasias , Sepse , Humanos , Unidades de Terapia Intensiva , Incidência , Estado Terminal , Estudos Retrospectivos , Hipovolemia , Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/etiologia , Fatores de Risco , Neoplasias/complicações , Neoplasias/epidemiologia
2.
Neurol Sci ; 44(5): 1555-1561, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36599976

RESUMO

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal lymphoma exclusively occurring within the central nervous system. Inflammatory brain lesions as "sentinel lesions" of PCNSL are very rare. We present a rare case of PCNSL with preceding inflammatory lesions in an immunocompetent patient who underwent two biopsies, one craniotomy and two genetic testing. CASE REPORT: A 66-year-old male patient presented with left limb weakness and ataxia. Brain magnetic resonance imaging showed a contrast-enhancing lesion with perifocal brain edema in the near midline of right frontal lobe. Histological examination of a brain biopsy specimen revealed inflammatory lesion characteristics with infiltration of T-cell dominant lymphocytes and few B-cell. Given that the patient developed cerebral hematoma after biopsy, lesion resection by craniotomy was performed. An excised sample demonstrated mixed T-cell and B-cell infiltrating inflammatory lesions. Four months after total resection of the right frontal lobe lesion, another lesion appeared in the left frontal parietal lobe, which was diagnosed as diffuse large B-cell lymphoma by biopsy. In addition, genetic testing of the lesions at two different locations was performed, and the results showed that the inflammatory lesions had the same three gene (RELN, PCLO, and CREBBP) mutations as PCNSL. Interestingly, the three mutated genes are associated with tumor. CONCLUSION: Our present case is the first to demonstrate inflammatory brain lesions heralding PCNSL from genetic and pathological perspectives. This may help clinicians to select new auxiliary diagnostic methods for timely diagnosis of patients with suspected PCNSL.


Assuntos
Neoplasias Encefálicas , Neoplasias do Sistema Nervoso Central , Linfoma Difuso de Grandes Células B , Masculino , Humanos , Idoso , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/patologia , Neoplasias Encefálicas/diagnóstico por imagem , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patologia , Encéfalo/patologia , Imageamento por Ressonância Magnética , Sistema Nervoso Central/patologia , Neoplasias do Sistema Nervoso Central/diagnóstico por imagem , Neoplasias do Sistema Nervoso Central/genética
3.
Biomed Microdevices ; 21(3): 64, 2019 07 04.
Artigo em Inglês | MEDLINE | ID: mdl-31273462

RESUMO

Sample deposition based on micro-droplet ejection has broad application prospects in the field of biomedicine. Ejection of RPMI-1640 medium (with and without cells) is investigated experimentally using a home-build electrohydrodynamic (EHD) ejection system, consisting of a liquid supplier and a nozzle, a high voltage source, a droplet collector, and a high speed photography module. High electric voltage is applied between the nozzle and the droplet collector. The liquid surface is electrically charged and the ejection takes place when electric force overcomes the surface tension. The ejection process is studied by using high speed photography and image processing. At low voltage, a stable ejection state is established with ejection frequency ranging from a few to a few tens of Hertz. At high voltage, another stable ejection state is reached with ejection frequency as high as 1300 Hz. At the transition voltage range, the ejection exhibits a periodic behaviour. During each cycle, the meniscus rapidly oscillates with gradually increased amplitude, and with several non-uniform droplets ejected at the final stage of the cycle. Human peripheral blood mononuclear cells, after ejection, shows survival rates higher than 79%, manifesting EHD ejection as a promising technique for cell printing.


Assuntos
Meios de Cultura , Técnicas Citológicas/instrumentação , Eletricidade , Hidrodinâmica , Cinética , Impressão/instrumentação
4.
Psychol Rep ; 120(2): 206-218, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28558623

RESUMO

In the past 10 years, thousands of people have claimed to be affected by trypophobia, which is the fear of objects with small holes. Recent research suggests that people do not fear the holes; rather, images of clustered holes, which share basic visual characteristics with venomous organisms, lead to nonconscious fear. In the present study, both self-reported measures and the Preschool Single Category Implicit Association Test were adapted for use with preschoolers to investigate whether discomfort related to trypophobic stimuli was grounded in their visual features or based on a nonconsciously associated fear of venomous animals. The results indicated that trypophobic stimuli were associated with discomfort in children. This discomfort seemed to be related to the typical visual characteristics and pattern properties of trypophobic stimuli rather than to nonconscious associations with venomous animals. The association between trypophobic stimuli and venomous animals vanished when the typical visual characteristics of trypophobic features were removed from colored photos of venomous animals. Thus, the discomfort felt toward trypophobic images might be an instinctive response to their visual characteristics rather than the result of a learned but nonconscious association with venomous animals. Therefore, it is questionable whether it is justified to legitimize trypophobia.


Assuntos
Medo/psicologia , Transtornos Fóbicos/diagnóstico , Pré-Escolar , Feminino , Humanos , Masculino , Transtornos Fóbicos/psicologia , Estimulação Luminosa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA